AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds.
AIxMed has raised $2.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
AIxMed's investors include Taiwania Capital Management Corporation.
AIxMed is headquartered in Santa Clara, United States.
AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds.
AIxMed is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AIxMed — Funding & Investors." VCBacked, April 27, 2023, https://www.vcbacked.co/company/aixmed. Accessed August 14, 2026.
VCBacked. (2023). AIxMed — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aixmed
{{cite web |title=AIxMed — Funding & Investors |url=https://www.vcbacked.co/company/aixmed |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated